This company listing is no longer active
Flower One Holdings Past Earnings Performance
Past criteria checks 0/6
Flower One Holdings's earnings have been declining at an average annual rate of -42.3%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 59.8% per year.
Key information
-42.3%
Earnings growth rate
-31.2%
EPS growth rate
| Pharmaceuticals Industry Growth | 7.3% |
| Revenue growth rate | 59.8% |
| Return on equity | n/a |
| Net Margin | -48.4% |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Flower One Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 43 | -21 | 28 | 0 |
| 31 Mar 22 | 53 | -19 | 31 | 0 |
| 31 Dec 21 | 58 | -24 | 34 | 0 |
| 30 Sep 21 | 56 | -87 | 32 | 0 |
| 30 Jun 21 | 54 | -109 | 33 | 0 |
| 31 Mar 21 | 39 | -129 | 30 | 0 |
| 31 Dec 20 | 34 | -117 | 26 | 0 |
| 30 Sep 20 | 30 | -81 | 26 | 0 |
| 30 Jun 20 | 21 | -48 | 25 | 0 |
| 31 Mar 20 | 18 | -8 | 23 | 0 |
| 31 Dec 19 | 9 | 1 | 21 | 0 |
| 30 Sep 19 | 4 | 31 | 20 | 0 |
| 30 Jun 19 | 1 | 10 | 16 | 0 |
| 31 Mar 19 | 1 | -10 | 13 | 0 |
| 31 Dec 18 | 0 | -12 | 8 | 0 |
Quality Earnings: F11 is currently unprofitable.
Growing Profit Margin: F11 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: F11 is unprofitable, and losses have increased over the past 5 years at a rate of 42.3% per year.
Accelerating Growth: Unable to compare F11's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: F11 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (2.8%).
Return on Equity
High ROE: F11's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.